AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 59 filers reported holding AIMMUNE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $25,966,000 | -37.3% | 1,240,000 | -37.7% | 57.34% | -16.5% |
| Q2 2019 | $41,432,000 | -6.8% | 1,990,000 | 0.0% | 68.67% | +2.7% |
| Q1 2019 | $44,477,000 | -6.6% | 1,990,000 | 0.0% | 66.84% | +395.9% |
| Q4 2018 | $47,601,000 | -12.3% | 1,990,000 | 0.0% | 13.48% | +14.9% |
| Q3 2018 | $54,287,000 | -9.9% | 1,990,000 | -11.2% | 11.73% | +48.4% |
| Q2 2018 | $60,234,000 | -15.5% | 2,240,000 | 0.0% | 7.91% | -37.8% |
| Q1 2018 | $71,299,000 | -15.8% | 2,240,000 | 0.0% | 12.71% | -24.1% |
| Q4 2017 | $84,717,000 | +14.3% | 2,240,000 | -25.1% | 16.74% | +37.4% |
| Q3 2017 | $74,122,000 | +20.6% | 2,990,000 | 0.0% | 12.18% | +15.7% |
| Q2 2017 | $61,474,000 | -5.4% | 2,990,000 | 0.0% | 10.53% | -11.0% |
| Q1 2017 | $64,973,000 | +6.3% | 2,990,000 | 0.0% | 11.83% | -16.8% |
| Q4 2016 | $61,146,000 | +36.3% | 2,990,000 | 0.0% | 14.22% | +53.8% |
| Q3 2016 | $44,850,000 | +38.6% | 2,990,000 | 0.0% | 9.24% | +20.9% |
| Q2 2016 | $32,352,000 | -20.2% | 2,990,000 | 0.0% | 7.64% | -5.9% |
| Q1 2016 | $40,544,000 | -26.5% | 2,990,000 | 0.0% | 8.12% | -14.7% |
| Q4 2015 | $55,166,000 | -22.7% | 2,990,000 | +6.0% | 9.51% | -24.2% |
| Q3 2015 | $71,402,000 | – | 2,820,000 | – | 12.55% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 3,300,797 | $90,046,000 | 33.32% |
| Aisling Capital LLC | 1,990,000 | $54,287,000 | 11.73% |
| Foresite Capital Management III, LLC | 801,240 | $21,858,000 | 4.82% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 189,857 | $5,181,000 | 4.12% |
| AlpInvest Partners B.V. | 38,943 | $1,062,000 | 2.27% |
| Eventide Asset Management | 1,739,000 | $47,440,000 | 1.74% |
| Palo Alto Investors LP | 1,381,759 | $37,694,000 | 1.52% |
| Sofinnova Investments, Inc. | 222,295 | $6,064,000 | 0.54% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 553,000 | $15,086,000 | 0.54% |
| EMERALD ADVISERS, LLC | 486,666 | $13,276,000 | 0.49% |